These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 34557019)

  • 1. Metabolic Processes are Potential Biological Processes Distinguishing Nonischemic Dilated Cardiomyopathy from Ischemic Cardiomyopathy: A Clue from Serum Proteomics.
    Huang G; Huang Z; Peng Y; Wang Y; Liu W; Xue Y; Yang W
    Pharmgenomics Pers Med; 2021; 14():1169-1184. PubMed ID: 34557019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrative Proteomic Analysis Reveals the Cytoskeleton Regulation and Mitophagy Difference Between Ischemic Cardiomyopathy and Dilated Cardiomyopathy.
    Liu M; Zhai L; Yang Z; Li S; Liu T; Chen A; Wang L; Li Y; Li R; Li C; Tan M; Chen Z; Qian J
    Mol Cell Proteomics; 2023 Dec; 22(12):100667. PubMed ID: 37852321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differences in T cell-associated serum markers between ischemic cardiomyopathy and dilated cardiomyopathy.
    Huang Y; Xuan L; Xu Q; Wang J; Liu J
    J Thorac Dis; 2024 Jul; 16(7):4655-4665. PubMed ID: 39144301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinct Circulating Expression Profiles of Long Noncoding RNAs in Heart Failure Patients With Ischemic and Nonischemic Dilated Cardiomyopathy.
    Lin F; Gong X; Yu P; Yue A; Meng Q; Zheng L; Chen T; Han L; Cao H; Cao J; Liang X; Hu H; Li Y; Liu Z; Zhou X; Fan H
    Front Genet; 2019; 10():1116. PubMed ID: 31781171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcriptome analysis of human heart failure reveals dysregulated cell adhesion in dilated cardiomyopathy and activated immune pathways in ischemic heart failure.
    Sweet ME; Cocciolo A; Slavov D; Jones KL; Sweet JR; Graw SL; Reece TB; Ambardekar AV; Bristow MR; Mestroni L; Taylor MRG
    BMC Genomics; 2018 Nov; 19(1):812. PubMed ID: 30419824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiac Proteome Profiling in Ischemic and Dilated Cardiomyopathy Mouse Models.
    Lu D; Xia Y; Chen Z; Chen A; Wu Y; Jia J; Sun A; Zou Y; Qian J; Ge J
    Front Physiol; 2019; 10():750. PubMed ID: 31275164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Asporin is a Potential Promising Biomarker for Common Heart Failure.
    Zhang K; Wu M; Qin X; Wen P; Wu Y; Zhuang J
    DNA Cell Biol; 2021 Feb; 40(2):303-315. PubMed ID: 33605799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Time-ordered dysregulated ceRNA networks reveal disease progression and diagnostic biomarkers in ischemic and dilated cardiomyopathy.
    Bai Z; Sun H; Li X; Wu J; Yuan H; Zhang G; Yang H; Shi H
    Cell Death Discov; 2021 Oct; 7(1):296. PubMed ID: 34657123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrative bioinformatics analysis of potential therapeutic targets and immune infiltration characteristics in dilated cardiomyopathy.
    Yang Y; Liu P; Teng R; Liu F; Zhang C; Lu X; Ding Y
    Ann Transl Med; 2022 Mar; 10(6):348. PubMed ID: 35433958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of potential dilated cardiomyopathy-related targets by meta-analysis and co-expression analysis of human RNA-sequencing datasets.
    Yuan Z; Murakoshi N; Xu D; Tajiri K; Okabe Y; Aonuma K; Murakata Y; Li S; Song Z; Shimoda Y; Mori H; Aonuma K; Ieda M
    Life Sci; 2022 Oct; 306():120807. PubMed ID: 35841977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploring the Communal Pathogenesis, Ferroptosis Mechanism, and Potential Therapeutic Targets of Dilated Cardiomyopathy and Hypertrophic Cardiomyopathy
    Wang Z; Xia Q; Su W; Cao M; Sun Y; Zhang M; Chen W; Jiang T
    Front Cardiovasc Med; 2022; 9():824756. PubMed ID: 35282347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiac protein changes in ischaemic and dilated cardiomyopathy: a proteomic study of human left ventricular tissue.
    Roselló-Lletí E; Alonso J; Cortés R; Almenar L; Martínez-Dolz L; Sánchez-Lázaro I; Lago F; Azorín I; Juanatey JR; Portolés M; Rivera M
    J Cell Mol Med; 2012 Oct; 16(10):2471-86. PubMed ID: 22435364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regional mapping of myocardial hibernation phenotype in idiopathic end-stage dilated cardiomyopathy.
    Lionetti V; Matteucci M; Ribezzo M; Di Silvestre D; Brambilla F; Agostini S; Mauri P; Padeletti L; Pingitore A; Delsedime L; Rinaldi M; Recchia FA; Pucci A
    J Cell Mol Med; 2014 Mar; 18(3):396-414. PubMed ID: 24444256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene expression profiling reveals genes and transcription factors associated with dilated and ischemic cardiomyopathies.
    Qiao A; Zhao Z; Zhang H; Sun Z; Cui X
    Pathol Res Pract; 2017 May; 213(5):548-557. PubMed ID: 28318762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiac unloading by LVAD support differentially influences components of the cGMP-PKG signaling pathway in ischemic and dilated cardiomyopathy.
    Persoon S; Paulus M; Hirt S; Jungbauer C; Dietl A; Luchner A; Schmid C; Maier LS; Birner C
    Heart Vessels; 2018 Aug; 33(8):948-957. PubMed ID: 29546540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of cardiomyopathy-related core genes through human metabolic networks and expression data.
    Rong Z; Chen H; Zhang Z; Zhang Y; Ge L; Lv Z; Zou Y; Lv J; He Y; Li W; Chen L
    BMC Genomics; 2022 Jan; 23(1):47. PubMed ID: 35016605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma Metabolomic Profiles Differentiate Patients With Dilated Cardiomyopathy and Ischemic Cardiomyopathy.
    Zhao J; Yang S; Jing R; Jin H; Hu Y; Wang J; Gu M; Niu H; Zhang S; Chen L; Hua W
    Front Cardiovasc Med; 2020; 7():597546. PubMed ID: 33240942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploration of dilated cardiomyopathy for biomarkers and immune microenvironment: evidence from RNA-seq.
    Fang C; Lv Z; Yu Z; Wang K; Xu C; Li Y; Wang Y
    BMC Cardiovasc Disord; 2022 Jul; 22(1):320. PubMed ID: 35850644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myocardial Expression Analysis of Osteopontin and Its Splice Variants in Patients Affected by End-Stage Idiopathic or Ischemic Dilated Cardiomyopathy.
    Cabiati M; Svezia B; Matteucci M; Botta L; Pucci A; Rinaldi M; Caselli C; Lionetti V; Del Ry S
    PLoS One; 2016; 11(8):e0160110. PubMed ID: 27479215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrated microarray analysis to identify potential biomarkers and therapeutic targets in dilated cardiomyopathy.
    Zhang H; Huo J; Jiang W; Shan Q
    Mol Med Rep; 2020 Aug; 22(2):915-925. PubMed ID: 32626989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.